Becton Dickinson and Company (BDX)vsBionano Genomics Inc (BNGO)
BDX
Becton Dickinson and Company
$151.16
+1.07%
HEALTHCARE · Cap: $39.80B
BNGO
Bionano Genomics Inc
$1.17
-7.14%
HEALTHCARE · Cap: $14.46M
Smart Verdict
WallStSmart Research — data-driven comparison
Becton Dickinson and Company generates 77244% more annual revenue ($22.23B vs $28.74M). BDX leads profitability with a 5.1% profit margin vs -109.9%. BDX earns a higher WallStSmart Score of 65/100 (B-).
BDX
Strong Buy65
out of 100
Grade: B-
BNGO
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+9.9%
Fair Value
$200.45
Current Price
$151.16
$49.29 discount
Intrinsic value data unavailable for BNGO.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Earnings expanding 28.6% YoY
Reasonable price relative to book value
Areas to Watch
Moderate valuation
ROE of 4.7% — below average capital efficiency
5.1% margin — thin
Distress zone — elevated risk
3.6% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -84.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : BDX
The strongest argument for BDX centers on Price/Book, EPS Growth. PEG of 1.11 suggests the stock is reasonably priced for its growth.
Bull Case : BNGO
The strongest argument for BNGO centers on Price/Book.
Bear Case : BDX
The primary concerns for BDX are P/E Ratio, Return on Equity, Profit Margin.
Bear Case : BNGO
The primary concerns for BNGO are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
BDX profiles as a value stock while BNGO is a turnaround play — different risk/reward profiles.
BNGO carries more volatility with a beta of 1.62 — expect wider price swings.
BDX is growing revenue faster at 5.2% — sustainability is the question.
BDX generates stronger free cash flow (546M), providing more financial flexibility.
Bottom Line
BDX scores higher overall (65/100 vs 33/100). Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Becton Dickinson and Company
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.
Visit Website →Bionano Genomics Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Bionano Genomics, Inc. is a life science instrumentation company in the genome analysis space. The company is headquartered in San Diego, California.
Visit Website →Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?